Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Oncotarget|August 4, 2016
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical studyNicola Coppola, Lorenzo Onorato, Valentina Iodice, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 4, 2003
Complications after interventional sonography of focal liver lesions: a 22-year single-center experienceAntonio Giorgio, Luciano Tarantino, Giorgio de Stefano, et al.Future Oncology (London, England)|March 12, 2015
Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinomaGiovan Giuseppe Di Costanzo, Giorgio de Stefano, Raffaella Tortora, et al.Frontiers in Immunology|June 29, 2018
Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV InfectionNicola Coppola, Lorenzo Onorato, Marta Panella, et al.AJR. American Journal of Roentgenology|July 24, 2003
Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinomaAntonio Giorgio, Luciano Tarantino, Giorgio de Stefano, et al.Oncotarget|April 28, 2017
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-RafNicola Coppola, Giorgio de Stefano, Marta Panella, et al.European Journal of Gastroenterology & Hepatology|April 28, 2023
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinomaRaffaella Tortora, Nunzia Farella, Filomena Morisco, et al.Life (Basel, Switzerland)|April 30, 2021
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern ItalyMariantonietta Pisaturo, Giulia De Angelis, Paolo Maggi, et al.Tumori|May 10, 2018
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocolAndrea Casadei Gardini, Luca Faloppi, Giuseppe Aprile, et al.World Journal of Hepatology|August 31, 2016
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experienceCleo Study Group, Antonio Ascione, Luigi Elio Adinolfi, et al.Pageof 3